Metabolism and excretion of the benzodiazepine analogue etizolam in the horse.

This research looks into how the horse’s body absorbs, utilizes, and eliminates etizolam, a benzodiazepine analogue. Etizolam, currently approved for use in a few foreign countries, is showing up increasingly on the North American and European illicit drug markets. This study was conducted because the drug was found at a Kentucky racetrack, spurring a need to understand its actions in horse’s body to improve anti-doping measures.

Purpose of the Study

• The research aims to study the processes of metabolism and excretion of etizolam in horses.
• The objective is to build a detailed knowledge of how this drug interacts with the horse’s body – how it’s broken down (metabolized) and eliminated (excreted).
• By identifying potential metabolites and examining their presence in serum and urine samples, the researchers aim to improve anti-doping drug detection strategies in horse racing.

Methods Used in the Study

• The study involved a two-way crossover design, where etizolam was administered both intravenously and orally to three horses.
• Dosage was calibrated at 0.1 mg/kg of the horse’s body weight.
• Pre-administration and post-administration serum and urine samples were collected for analysis.
• The research also included in vitro metabolism studies using horse liver S9, supplementing the in vivo results.

Findings of the Study

• Several metabolites aside from the parent drug were discovered in both the serum and urine samples.
• The most abundant metabolite in terms of both signal intensity and lifespan of detection was α-hydroxy-etizolam. Consequently, this metabolite was deemed the most suitable for tracking and detecting for anti-doping purposes.

Implications and Conclusion of the Study

• Based on these findings, the study developed and validated analytical methods of detection.
• The methods were then applied to post-administration samples, resulting in excretion profiles. These profiles detail concentration levels of etizolam and its primary metabolites in the urine and serum.
• This information will guide future strategies in detecting illicit etizolam use in horse racing. Understanding the drug’s metabolism and excretion in the horse’s body can enhance the efficacy and reliability of anti-doping protocols.